Intraoperative extracorporeal membrane oxygenation for lung transplantation in cystic fibrosis patients: Predictors and impact on outcome
Cystic fibrosis (CF) is the most common genetically inherited disease in the Caucasian population [1]. Respiratory manifestations of CF include reduction of mucus clearance, chronic pulmonary infections, and bronchiectasis, causing a progressive respiratory failure that is the primary cause of death in CF patients. Advanced CF might be complicated by pulmonary hypertension, right ventricular hypertrophy, and right heart failure [2]. Bilateral lung transplantation (LUTX) is a viable option for CF, providing a significant survival benefit [3].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Vittorio Scaravilli, Letizia Corinna Morlacchi, Alessandra Merrino, Edoardo Piacentino, Davide Marasco, Alberto Zanella, Mario Nosotti, Lorenzo Rosso, Federico Polli, Francesco Blasi, Antonio Pesenti, Giacomo Grasselli Source Type: research
More News: Cardiology | Cystic Fibrosis | Genetics | Heart | Heart Failure | Heart Transplant | Hypertension | Lung Transplant | Pulmonary Hypertension | Respiratory Medicine | Transplants